| Literature DB >> 19194203 |
Christian M Capitini1, Joanne Derdak, Marybeth S Hughes, Cynthia P Love, Kristin Baird, Crystal L Mackall, Terry J Fry.
Abstract
Allogeneic stem cell transplantation (SCT) for solid tumors remains under investigation. We report a case of extended disease stability after a nonmyeloablative peripheral blood SCT for metastatic, refractory Ewing sarcoma. Of note, the patient developed metastatic disease to 2 unusual sites-the brain and small intestine. The allogeneic SCT environment may alter typical metastatic patterns, and may represent an ideal platform to manipulate and enhance the antitumor immune response. Further clinical trials are needed to evaluate the role for allogeneic SCT for this disease.Entities:
Mesh:
Year: 2009 PMID: 19194203 PMCID: PMC2644462 DOI: 10.1097/MPH.0b013e31819146e5
Source DB: PubMed Journal: J Pediatr Hematol Oncol ISSN: 1077-4114 Impact factor: 1.289